Medicine
fromwww.nature.com
2 days agoMulticentre gene therapy for OTOF-related deafness followed up to 2.5 years
Gene therapy using AAV1-hOTOF shows promise for treating autosomal recessive deafness without dose-limiting toxicities in a multicenter trial.